Clinical Trial Update: Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing veliparib with carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in untreated advanced or metastatic squamous non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Squamous Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED